188 related articles for article (PubMed ID: 36628250)
1. Deciphering cervical cancer-associated biomarkers by integrated multi-omics approach.
Li X; Abdel-Maksoud MA; Iqbal I; Mubarak A; Farrag MA; Haris M; Alghamdi S; Ain QU; Almekhlafi S
Am J Transl Res; 2022; 14(12):8843-8861. PubMed ID: 36628250
[TBL] [Abstract][Full Text] [Related]
2. Estimation of hub genes and exploration of multi-omics level alterations in the landscape of lung adenocarcinoma.
Li G; Atiq W; Hashmi MF; Ibrahim SS; Al Abdulsalam KA; Kadham MJ; Al-Azzawi AKJ; Aufy M; Abdel-Maksoud MA
Am J Transl Res; 2023; 15(3):1550-1568. PubMed ID: 37056815
[TBL] [Abstract][Full Text] [Related]
3. Identification of Hub Genes as Potential Prognostic Biomarkers in Cervical Cancer Using Comprehensive Bioinformatics Analysis and Validation Studies.
Xue H; Sun Z; Wu W; Du D; Liao S
Cancer Manag Res; 2021; 13():117-131. PubMed ID: 33447084
[TBL] [Abstract][Full Text] [Related]
4. Identification of hub genes associated with head and neck squamous cell carcinoma by integrated bioinformatics approach and RNA-seq validation analysis.
Shabeer A; Mustafa S; Bukhari RS; Abdel-Maksoud MA; Almutairi SM; Al-Qahtani WH; Chandio K; Khan NY; Gul J; Aufy M
Am J Cancer Res; 2023; 13(4):1259-1277. PubMed ID: 37168331
[TBL] [Abstract][Full Text] [Related]
5. Comprehensively analyzing the genetic alterations, and identifying key genes in ovarian cancer.
Tang Q; Atiq W; Mahnoor S; Abdel-Maksoud MA; Aufy M; Yaz H; Zhu J
Oncol Res; 2023; 31(2):141-156. PubMed ID: 37304238
[TBL] [Abstract][Full Text] [Related]
6. Identification of EPHX2 and RMI2 as two novel key genes in cervical squamous cell carcinoma by an integrated bioinformatic analysis.
Liu J; Nie S; Gao M; Jiang Y; Wan Y; Ma X; Zhou S; Cheng W
J Cell Physiol; 2019 Nov; 234(11):21260-21273. PubMed ID: 31041817
[TBL] [Abstract][Full Text] [Related]
7. The discovery of promising candidate biomarkers in kidney renal clear cell carcinoma: evidence from the in-depth analysis of high-throughput data.
Li X; Li M; Zhao T; Zhang J
Am J Cancer Res; 2023; 13(9):4288-4304. PubMed ID: 37818073
[TBL] [Abstract][Full Text] [Related]
8. Decreased Expression of NUSAP1 Predicts Poor Overall Survival in Cervical Cancer.
Xie Q; Ou-Yang W; Zhang M; Wang H; Yue Q
J Cancer; 2020; 11(10):2852-2863. PubMed ID: 32226503
[No Abstract] [Full Text] [Related]
9. Bioinformatics analysis of the transcriptional expression of minichromosome maintenance proteins as potential indicators of survival in patients with cervical cancer.
Wu B; Xi S
BMC Cancer; 2021 Aug; 21(1):928. PubMed ID: 34404366
[TBL] [Abstract][Full Text] [Related]
10. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases.
Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P
Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537
[No Abstract] [Full Text] [Related]
11. Integrated analysis of key microRNAs /TFs /mRNAs/ in HPV-positive cervical cancer based on microRNA sequencing and bioinformatics analysis.
Yuan Y; Shi X; Li B; Peng M; Zhu T; Lv G; Liu L; Jin H; Li L; Qin D
Pathol Res Pract; 2020 Jun; 216(6):152952. PubMed ID: 32307200
[TBL] [Abstract][Full Text] [Related]
12. Identification of Metastasis-Associated Biomarkers in Synovial Sarcoma Using Bioinformatics Analysis.
Song Y; Liu X; Wang F; Wang X; Cheng G; Peng C
Front Genet; 2020; 11():530892. PubMed ID: 33061942
[TBL] [Abstract][Full Text] [Related]
13. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
[TBL] [Abstract][Full Text] [Related]
14. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
[TBL] [Abstract][Full Text] [Related]
15. Screening of hub genes associated with prognosis in non-small cell lung cancer by integrated bioinformatics analysis.
Zeng Y; Li N; Chen R; Liu W; Chen T; Zhu J; Zeng M; Cheng J; Huang J
Transl Cancer Res; 2020 Nov; 9(11):7149-7164. PubMed ID: 35117319
[TBL] [Abstract][Full Text] [Related]
16. Significant prognostic values of differentially expressed-aberrantly methylated hub genes in breast cancer.
Qi L; Zhou B; Chen J; Hu W; Bai R; Ye C; Weng X; Zheng S
J Cancer; 2019; 10(26):6618-6634. PubMed ID: 31777591
[No Abstract] [Full Text] [Related]
17. Identification of key biomarkers associated with development and prognosis in patients with ovarian carcinoma: evidence from bioinformatic analysis.
Shen J; Yu S; Sun X; Yin M; Fei J; Zhou J
J Ovarian Res; 2019 Nov; 12(1):110. PubMed ID: 31729978
[TBL] [Abstract][Full Text] [Related]
18. Identification of Hub Genes Associated With Immune Infiltration and Predict Prognosis in Hepatocellular Carcinoma via Bioinformatics Approaches.
Chen H; Wu J; Lu L; Hu Z; Li X; Huang L; Zhang X; Chen M; Qin X; Xie L
Front Genet; 2020; 11():575762. PubMed ID: 33505422
[TBL] [Abstract][Full Text] [Related]
19. Functional analysis of tumor-derived immunoglobulin lambda and its interacting proteins in cervical cancer.
Wang J; Huang J; Ding H; Ma J; Zhong H; Wang F; Chen Y; Peng H
BMC Cancer; 2023 Oct; 23(1):929. PubMed ID: 37784026
[TBL] [Abstract][Full Text] [Related]
20. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
